CMS GUIDE and other dementia care models are under active review in 2026 because federal regulators are reshaping which programs continue and how they pay for care. GUIDE (Guiding an Improved Dementia Experience) is a voluntary, eight-year Medicare payment model launched July 1, 2024 that covers dementia care coordination and caregiver education and respite, and it remains active with updated payment terms this year, according to CMS's GUIDE Payment Methodology Paper v3.0. For family caregivers, the practical question is not whether GUIDE survives — it does — but whether their loved one's health system participates, whether they qualify for respite funding, and whether a competing model offers anything comparable. The sections below walk through eligibility, the respite benefit, what happened to other CMS models, and what independent research says about whether any of this actually helps caregivers.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Read the official notice from CMS — Use this primary source to verify the official announcement.
- Read the official guidance from Ou — Use this primary source to verify the official guidance.
Table of Contents
- What Is the GUIDE Model, and Is It Still Running in 2026?
- Who Qualifies for the Caregiver Respite Benefit, and How Much Does It Pay?
- Why Did CMS End Some Models While Keeping GUIDE?
- Does Structured Dementia Care Actually Change Outcomes for Caregivers?
- Why Many Eligible Families Still Aren't Using GUIDE
- Frequently Asked Questions
What Is the GUIDE Model, and Is It Still Running in 2026?
GUIDE is a nationwide Medicare payment model that pays participating health systems and practices to provide structured dementia care management, including a 24/7 support line, caregiver training, and respite services, rather than billing for scattered individual visits. CMS designed it to run for eight years starting July 1, 2024, and the model's own fact sheet describes it as a direct response to the gap between what dementia caregiving requires and what fee-for-service Medicare traditionally reimburses, according to CMS's GUIDE Model Overview Fact Sheet. The model is not shrinking.
CMS's GUIDE Payment Methodology Paper reached version 3.0, effective June 1, 2026, which updated payment rates and the caregiver respite cap for the new performance year — a sign that CMS is actively revising and continuing the model rather than winding it down, according to CMS's GUIDE Payment Methodology Paper v3.0. As of July 8, 2025, CMS listed 330 organizations participating in GUIDE nationwide, published in its Participant List, according to CMS. That number reflects health systems, hospitals, and medical practices that enrolled as GUIDE participants — not every provider a caregiver might see, so confirming participation for a specific neurologist, geriatrician, or hospital system is a necessary first step.
Who Qualifies for the Caregiver Respite Benefit, and How Much Does It Pay?
GUIDE's respite benefit is restricted to a specific group: Original Medicare (Parts A and B) beneficiaries with moderate-to-severe dementia who have an identified unpaid caregiver. Medicare Advantage enrollees and hospice beneficiaries do not qualify, according to CMS program materials summarized by AHCA/NCAL.
For performance year 2025, CMS set the respite cap at $2,563 per patient, payable toward in-home respite, adult day services, or short-term facility-based care for the unpaid caregiver's benefit, according to CMS's MLN7172818 fact sheet. That figure applies per patient, not per caregiver, so a family sharing caregiving duties draws from one pooled amount rather than separate allotments. A caregiver considering this benefit should check these points before assuming eligibility: Because the cap changed between performance years under the v3.0 methodology update, a caregiver already receiving respite funding should confirm the current-year amount with their GUIDE care navigator rather than relying on the 2025 figure indefinitely.
- Is the person with dementia enrolled in Original Medicare, not a Medicare Advantage plan?
- Does their diagnosis documentation reflect moderate-to-severe dementia?
- Is there a specific unpaid caregiver identified in their care plan?
- Is the treating health system or practice a listed GUIDE participant?
- Has the patient enrolled in hospice? If so, respite funding under GUIDE does not apply.
Why Did CMS End Some Models While Keeping GUIDE?
In March 2025, CMS's Innovation Center reviewed its entire portfolio of payment models and ended four of them early — Maryland Total Cost of Care, Primary Care First, ESRD Treatment Choices, and Making Care Primary — effective December 31, 2025, citing cost performance. At the same time, CMS determined that its remaining active models, GUIDE among them, could continue either unchanged or with modification, according to CMS's March 12, 2025 press release.
That distinction matters for care planning: GUIDE was not swept up in the same cost-driven termination that closed four other models, and the subsequent v3.0 payment update confirms CMS chose modification over cancellation. A caregiver whose provider participates in GUIDE does not need to treat the broader portfolio review as a threat to that specific program, though the review signals that CMS continues to evaluate every model against cost and outcome data on an ongoing basis.
Does Structured Dementia Care Actually Change Outcomes for Caregivers?
The largest independent test of this question is the federally funded D-CARE trial, which enrolled 2,176 people with dementia and their caregivers between June 2019 and August 2023 and compared health-system-based care, community-based care, and usual care over 18 months. The trial found no significant difference among the three models on patients' behavioral symptoms or on caregiver strain, according to JAMA, reported by HCPLive. The trial did find one meaningful benefit: both the health-system and community-based models raised caregivers' self-efficacy — their confidence in managing dementia-related challenges — above usual care.
That gain appeared within six months and held through the full 18-month follow-up, and the study's authors tied the finding directly to GUIDE-participating health systems, since GUIDE follows the same structured-coordination approach tested in the trial, according to the OU Health summary of the JAMA D-CARE trial. For a caregiver deciding whether to pursue a GUIDE-enrolled provider, this means the realistic benefit is confidence and skill in managing day-to-day caregiving tasks, not necessarily a measurable drop in the care recipient's behavioral symptoms or a documented reduction in caregiver burden on standard strain scales. Both outcomes matter, but they are not the same thing, and D-CARE's results suggest coordination models deliver more reliably on the former.
Why Many Eligible Families Still Aren't Using GUIDE
LeadingAge, a national association of aging-services providers, identified low awareness among families and physicians as a top practical barrier preventing eligible caregivers from enrolling in GUIDE and using its care-coordination and respite benefits. CMS responded by releasing a public-facing explainer video on September 21, 2026, aimed at closing that awareness gap, according to LeadingAge.
This gap means eligibility alone does not guarantee access. A caregiver whose family member sees a GUIDE-participating provider may still miss the respite benefit simply because no one on the care team raised it. Asking a treating physician or care coordinator directly — "Is this practice enrolled in the GUIDE model, and can we use the respite benefit?" — remains the most direct way to close that gap, since the enrollment decision sits with the provider, not the patient.
Frequently Asked Questions
Does Medicare Advantage cover the GUIDE respite benefit?
No. Respite funding under GUIDE is limited to Original Medicare (Parts A and B) beneficiaries with an identified unpaid caregiver; Medicare Advantage enrollees are excluded, according to CMS program materials summarized by AHCA/NCAL.
Is GUIDE at risk of being cut like other CMS models?
No. CMS ended four other payment models in March 2025 for cost reasons but kept GUIDE active, and its payment methodology was updated to version 3.0 in June 2026, confirming ongoing operation.
Will enrolling in a GUIDE-participating health system reduce challenging dementia behaviors?
The D-CARE trial found no significant difference in patient behavioral symptoms between structured care models and usual care over 18 months, though caregiver confidence improved under structured models.
You Might Also Like
- Home-Based Dementia Care Research Priorities in 2026: Care-Planning Implications for Adult Children
- NHATS and NSOC Dementia Care Data Priorities in 2026: Questions Adults With Memory Concerns Can Ask About the Research
- The 2026 NIA Workshop on Comprehensive Dementia Care Models: Cost and Access Questions for Adult Children
